TABLE 3.
Neuroendocrine tumor, sickness of Alzheimer, and disease of Parkinson animal models are summarized.
Disease | Model | Characteristics | Reference | Plant name | Part used | Neuroprotective activity | Reference |
---|---|---|---|---|---|---|---|
GMB | Xenograft/HT1080 (human cell line) | IDH1 mutant (MGG152) | Tateishi et al. (2015) | Fumaria indica (Hausskn.) Pugsley | Leaf | Significant activity of ethanolic extract on rat cognitive dysfunctions. Potential antianxiety activity of leaf extract; preclinical study | (Singh et al., 2013a; Singh et al., 2013b) |
Xenograft/LNT-229 and LN-308 (human cell line) | IDH1 R132C mutant (HT1080) | Szabo et al. (2016) | |||||
Xenograft/BT111 (TIC), BT116 (TIC) | Unmethylated MGMT (BT111) and (BT116) | Sharpe et al. (2015) | |||||
Xenograft/U251 (human cell line) | N/A | Sharpe et al. (2015) | Alhagipseud alhagi (M. Bieb) Desv. ex B. Keller &Shap. | Whole plant | Traditionally used for neuroprotective disorders. Compounds having neuroprotective activity such as flavanone glycosides and alkaloids such as β-phenethylamine and tetrahydroisoquinoline have been reported | (Ghosal et al., 1974; Singh et al., 1999; Muhammad et al., 2015) | |
Allograf GL261-Luc (mouse cell line) | N/A | Zeng et al. (2013) | |||||
AD | PDAPP | Unspecified microgliosis and resistant microglia are both related to diseases | Cohen et al. (2013) | Premna mucronata Roxb | Whole plant | Luteolin and apigenin are reported, and they are reported to be neuroprotective | Dave et al. (2015) |
Tg2576 | Plaques are related to neural stem cells that have been allocated a particular character | Elfenbein et al. (2007) | |||||
APP23 | In specifically, the glial cell is associated in fibrils deposits, epidemic, and also cytosis | Karch and Goate, (2015) | Semecarpus anacardium L.f | Fruits | Stress-induced neuroprotective activity | Shukla et al. (2000) | |
J20 | Microgliosis and astrogliosis are two forms of engraftment that may occur in the brain and have negative consequences | (Hartley et al., 2015) | Sida cordifolia L | Whole plant | Ameliorative effect in parkinsonism | SJ and Kumar B, (2020) | |
PD | MPTP Neurotoxin: inhibition of complex I | No time passes during the process of accumulation, and cholinergic neurotoxicity occurs quickly and severely, resulting in a major motor deficit | Dauer and Przedborski, (2003) | Tinospora cordifolia (Thunb.) Miers | Stems | Suppresses neuro-inflammation in Parkinsonian Mouse Model; potential neuro-regenerative candidate against glutamate induced excitotoxicity: an in vitro perspective | (Sharma et al., 2018; Birla et al., 2019) |
6-OHDA Suppression of 6-OHDA suppression of enzyme I as well as antioxidant distress caused by neurotoxic | Heterogeneous sensory impairments, no synuclein aggregation, fast and severe cholinergic deterioration | Schober and research, (2004) | Trichosanthes dioica Roxb | Rhizome | Neuropharmacological properties of root | Bhattacharya and Haldar, (2013) | |
UCH-L1 I93M mutation | In rodents, there were no synuclein aggregation, cholinergic neurotoxicity, or minor motor impairments | Setsuie et al. (2007) |